Try our beta test site
1 study found for:    NCT01494701
Show Display Options
Rank Status Study
1 Completed An Open-label Safety, Tolerability, and Dose-range Finding Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
Intervention: Drug: ISIS-SMNRx

Study has passed its completion date and status has not been verified in more than two years.